, Tracking Stock Market Picks
Enter Symbol:
Santarus, Inc. (SNTS) [hlAlert]

up 775.61 %

Santarus, Inc. (SNTS) rated Overweight by Thomas Weisel

Posted on: Friday,  Apr 16, 2010  8:25 AM ET by Thomas Weisel

Thomas Weisel rated Overweight Santarus, Inc. (NASDAQ: SNTS) on 04/16/2010, when the stock price was $3.65. Since
then, Santarus, Inc. has gained 775.62% as of 12/31/2014's recent price of $31.96.
If you would have followed this Thomas Weisel's recommendation on SNTS, you would have gained 775.61% of your investment in 1720 days.

Santarus Inc is a specialty pharmaceutical company focused on acquiring, developing and commercializing proprietary products for the prevention and treatment of gastrointestinal diseases and disorders.

At Thomas Weisel Partners, the role of Research is to contribute to our clients' decision process in ways that lead to better investment decisions. We cover the key growth sectors of the economy including Consumer, Energy, Financial Services, Healthcare, Internet, Media & Telecom, Metals & Mining and Technology.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/16/2010 8:25 AM Buy
as of 12/31/2010
1 Week up  4.12 %
1 Month up  18.84 %
3 Months up  8.97 %
1 YTD down  -10.13 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy